Similar articles

• Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels.

  Argel MI, Vittone L, Grassi AO, Chiappe LE, Chiappe GE, Cingolani HE. Argel MI, et al. J Mol Cell Cardiol. 1980 Oct;12(10):939-54. doi: 10.1016/0022-2828(80)90023-1. J Mol Cell Cardiol. 1980. PMID: 6257913 No abstract available.
• [Significance of studies on cyclic nucleotide metabolism for practical medicine].

  Dorofeev GI, Ivashkin VT. Dorofeev GI, et al. Ukr Biokhim Zh (1978). 1981 Mar-Apr;53(2):87-100. Ukr Biokhim Zh (1978). 1981. PMID: 6266107 Review. Russian.
• Possibilities for drug development based on the cyclic AMP system.

  Amer MS, McKinney GR. Amer MS, et al. Life Sci. 1973 Oct 1;13(7):753-67. doi: 10.1016/0024-3205(73)90066-0. Life Sci. 1973. PMID: 4358272 Review. No abstract available.
• Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease.

  Minton JP, Foecking MK, Webster DJ, Matthews RH. Minton JP, et al. Am J Obstet Gynecol. 1979 Sep 1;135(1):157-8. Am J Obstet Gynecol. 1979. PMID: 224703 No abstract available.
• Deranged metabolism of cyclic nucleotides in liver diseases.

  Matsushima T, Maekubo H, Yoshida T, Taneda H, Yoshida J, Miyazaki T, Okada F. Matsushima T, et al. Horm Metab Res. 1985 Jun;17(6):306-7. doi: 10.1055/s-2007-1013525. Horm Metab Res. 1985. PMID: 2991101